NHS advises women with irregular periods to test for PMOS

The NHS has issued new draft guidance recommending that up to four million women with irregular periods be investigated for polyendocrine metabolic ovarian syndrome (PMOS), which affects up to 13% of women of reproductive age. The guidance emphasizes the need for thorough assessment, including blood tests and ultrasounds, and advocates for regular annual reviews to monitor associated health risks such as diabetes and cardiovascular disease. It also highlights the importance of early diagnosis and consistent management to improve health outcomes, particularly among minority communities.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل